These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27027198)

  • 1. Rosacea: clinical features and treatment.
    Lavers I
    Nurs Stand; 2016 Mar; 30(31):52-9; quiz 60. PubMed ID: 27027198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosacea: an update.
    Buechner SA
    Dermatology; 2005; 210(2):100-8. PubMed ID: 15724091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.
    Two AM; Wu W; Gallo RL; Hata TR
    J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.
    Steinhoff M; Schmelz M; Schauber J
    Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosacea: New Concepts in Classification and Treatment.
    van Zuuren EJ; Arents BWM; van der Linden MMD; Vermeulen S; Fedorowicz Z; Tan J
    Am J Clin Dermatol; 2021 Jul; 22(4):457-465. PubMed ID: 33759078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-focused Solutions in Rosacea Management: Treatment Challenges in Special Patient Groups.
    Cices A; Alexis AF
    J Drugs Dermatol; 2019 Jul; 18(7):608-612. PubMed ID: 31329380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea: Clinical Aspects and Treatments.
    Geng R; Bourkas AN; Sibbald RG
    Adv Skin Wound Care; 2023 Dec; 36(12):626-634. PubMed ID: 37983575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatments for rosacea.
    Layton AM
    Clin Dermatol; 2017; 35(2):207-212. PubMed ID: 28274361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the management of rosacea in primary care.
    Tidman MJ
    Practitioner; 2014 Oct; 258(1775):27-30, 3. PubMed ID: 25591285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rosacea].
    Barco D; Alomar A
    Actas Dermosifiliogr; 2008 May; 99(4):244-56. PubMed ID: 18394399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in rosacea and acne: Implications for patient care.
    Fleischer AB
    J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for Use of Combination Therapy in Rosacea.
    Stein Gold L; Baldwin H; Harper JC
    J Drugs Dermatol; 2020 Oct; 19(10):929-934. PubMed ID: 33026776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosacea: an update on medical therapies.
    Chang BP; Kurian A; Barankin B
    Skin Therapy Lett; 2014; 19(3):1-4. PubMed ID: 25188361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosacea in the pediatric population.
    Lacz NL; Schwartz RA
    Cutis; 2004 Aug; 74(2):99-103. PubMed ID: 15379362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for acne rosacea.
    Goldgar C; Keahey DJ; Houchins J
    Am Fam Physician; 2009 Sep; 80(5):461-8. PubMed ID: 19725487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.
    Del Rosso JQ; Gallo RL; Kircik L; Thiboutot D; Baldwin HE; Cohen D
    J Drugs Dermatol; 2012 Jun; 11(6):694-700. PubMed ID: 22648215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rosacea].
    Decauchy F; Beauvais L; Meunier L; Meynadier J
    Rev Prat; 1993 Nov; 43(18):2344-8. PubMed ID: 8048975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of rosacea: redness, telangiectasia, and rosacea.
    Cribier B
    Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S184-91. PubMed ID: 22183097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of altered cutaneous immune responses in the induction and persistence of rosacea.
    Margalit A; Kowalczyk MJ; Żaba R; Kavanagh K
    J Dermatol Sci; 2016 Apr; 82(1):3-8. PubMed ID: 26747056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of rosacea. Redness, telangiectasia, and rosacea].
    Cribier B
    Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S129-37. PubMed ID: 21907872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.